Hallucinogens and Their Therapeutic Use: A Literature Review

Area of Science:

• Psychiatry and Pharmacology
• Neuroscience
• Clinical Psychology

Background:

• Recent resurgence in exploring therapeutic potential of psychedelic substances.
• Growing interest in non-traditional treatments for psychiatric conditions.

Purpose of the Study:

• To review published literature on psychotherapeutic uses of hallucinogens in psychiatric disorders.
• To synthesize findings on various psychedelic compounds and their efficacy.

Main Methods:

• Literature review of published studies on hallucinogens in psychiatric treatment.
• Analysis of studies evaluating substances like psilocybin, ketamine, and LSD.
• Inclusion of research on conditions from depression to autism spectrum disorder.

Main Results:

• Multiple hallucinogenic substances (ayahuasca, ibogaine, ketamine, LSD, MDMA, psilocybin) show promise.
• Largest body of research focuses on treatment of substance use disorders.
• Majority of reviewed studies indicate significant positive associations with symptom improvement.

Conclusions:

• Hallucinogens demonstrate potential in treating various psychiatric disorders.
• Current research is limited by small sample sizes, inconsistent measures, and poor study design.
• Well-designed, standardized studies are crucial to validate risks and benefits of hallucinogens in psychiatric care.